Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

N-terminal determinants of IκBα necessary for the cytoplasmic regulation of c-Rel

Abstract

IκBα is a dual regulator of Rel/NF-κB transcription factors. IκBα retains inactive NF-κB dimers in the cytoplasm, and inhibits their DNA-binding and transcriptional activities in the nucleus. Our previous studies identified discrete functional domains in IκBα responsible for the cytoplasmic and nuclear regulation of c-Rel. Determinants necessary for regulating c-Rel in the nucleus mapped to the central ankyrin domain of IκBα and a few negatively-charged amino acids that follow in the C-terminal PEST region. In contrast, sequences involved in the cytoplasmic regulation of c-Rel reside in the N-terminal and central ankyrin domains of IκBα. Here, we present a refined mapping of the N-terminal determinants of IκBα necessary for the cytoplasmic regulation of c-Rel homodimers. We demonstrate that amino acids 48–58 in p40/IκBα are essential to block the nuclear localization of c-Rel dimers. These data define a region of IκBα that may be required for optimal masking of the c-Rel NLS, or for the nuclear export of c-Rel/IκBα complexes. These findings highlight a novel function for the N-terminus of IκBα in the control of the subcellular localization of Rel/NF-κB dimers. Given the implication of deregulated NF-κB activity in hematopoietic and solid tumors, our findings predict that certain alterations in this domain of IκBα may have severe biological repercussions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D and Hay RT. . 1995 Mol. Cell. Biol. 15: 2689–2696.

  • Arenzana-Seisdedos F, Turpin P, Rodriguez M, Thomas D, Hay RT, Virelizier JL and Dargemont C. . 1997 J. Cell. Sci. 110: 369–378.

  • Baeuerle PA. . 1998 Cell 95: 729–731.

  • Barroga CF, Stevenson JK, Schwarz EM and Verma IM. . 1995 Proc. Natl. Acad. Sci. USA 92: 7637–7641.

  • Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA and Baldwin Jr AS. . 1992 Genes Dev. 6: 1899–1913.

  • Beg AA, Sha WC, Bronson RT and Baltimore D. . 1995 Genes Dev. 9: 2736–2746.

  • Brown K, Park S, Kanno T, Franzoso G and Siebenlist U. . 1993 Proc. Natl. Acad. Sci. USA 90: 2532–2536.

  • Cabannes E, Khan G, Aillet F, Jarrett R and Hay R. . 1999 Oncogene 18: 3063–3070.

  • Chiao PJ, Miyamoto S and Verma IM. . 1994 Proc. Natl. Acad. Sci. USA 91: 28–32.

  • Ernst MK, Dunn LL and Rice NR. . 1995 Mol. Cell. Biol. 15: 872–882.

  • Ganchi PA, Sun S-C, Greene WC and Ballard DW. . 1992 Mol. Cell. Biol. 3: 1339–1352.

  • Ghosh S, May MJ and Kopp EB. . 1998 Annu. Rev. Immunol. 16: 225–260.

  • Haskill S, Beg AA, Tompkins SM, Morris JS and Baldwin Jr AS. . 1991 Cell 65: 1281–1289.

  • Hatada EN, Naumann M and Scheidereit C. . 1993 EMBO J. 12: 2781–2788.

  • Huxford T, Huang D-B, Malek S and Ghosh G. . 1998 Cell 95: 759–770.

  • Inoue J-I, Kerr LD, Rashid D, Davis N, Bose Jr HR and Verma IM. . 1992 Proc. Natl. Acad. Sci. USA 89: 4333–4337.

  • Jacobs MD and Harrison SC. . 1998 Cell 95: 749–758.

  • Jaffray E, Wood KM and Hay RT. . 1995 Mol. Cell. Biol. 15: 2166–2172.

  • Johnson C, Van Antwerp D and Hope TJ. . 1999 EMBO J. 18: 6682–6693.

  • Kerr LD, Inoue J-I, Davis N, Link E, Baeuerle PA, Bose HR and Verma IM. . 1991 Genes Dev. 5: 1464–1476.

  • Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt H, Chen C-H, Rosen CA and Stewart CL. . 1996 Mol. Cell. Biol. 16: 2341–2349.

  • Kumar S and Gélinas C. . 1993 Proc. Natl. Acad. Sci. USA 90: 8962–8966.

  • Kunsch C, Ruben SM and Rosen CA. . 1992 Mol. Cell. Biol. 12: 4412–4421.

  • Latimer M, Ernst MK, Dunn LL, Drutskaya M and Rice NR. . 1998 Mol. Cell. Biol. 18: 2640–2649.

  • Le Bail O, Schmidt-Ullrich R and Israël A. . 1993 EMBO J. 12: 5043–5049.

  • Luque I and Gélinas C. . 1998 Mol. Cell. Biol. 18: 1213–1224.

  • Malek S, Huxford T and Ghosh G. . 1998 J. Biol. Chem. 273: 25427–25435.

  • Maniatis T. . 1997 Science 278: 818–819.

  • Nakayama K, Shimizu H, Mitomo K, Watanabe T, Okamoto S-I and Yamamoto K-I. . 1992 Mol. Cell. Biol. 12: 1736–1746.

  • Rayet B and Gélinas C. . 1999 Oncogene 18: 6938–6947.

  • Sachdev S, Hoffmann A and Hannink M. . 1998 Mol. Cell. Biol. 18: 2524–2534.

  • Sachdev S, Rottjakob EM, Diehl JA and Hannink M. . 1995 Oncogene 11: 811–823.

  • Scott ML, Fujita T, Liou HC, Nolan GP and Baltimore D. . 1993 Genes Dev. 7: 1266–1276.

  • Simeonidis S, Stauber D, Chen G, Hendrickson WA and Thanos D. . 1999 Proc. Natl. Acad. Sci. USA 96: 49–54.

  • Sovak M, Bellas R, Kim D, Zanieski G, Rogers A, Traish A and Sonenshein G. . 1997 J. Clin. Invest. 100: 2952–2960.

  • Sun S-C, Elwood J and Greene WC. . 1996 Mol. Cell. Biol. 16: 1058–1065.

  • Sun S-C, Ganchi PA, Ballard DW and Greene WC. . 1993 Science 259: 1912–1915.

  • Verma IM and Stevenson J. . 1997 Proc. Natl. Acad. Sci. USA 94: 11758–11760.

  • Xu X and Gélinas C. . 1997 Oncogene 14: 1521–1530.

  • Zabel U and Baeuerle PA. . 1990 Cell 61: 255–265.

  • Zabel U, Henkel T, dos Santos Silva M and Baeuerle PA. . 1993 EMBO J. 12: 201–211.

Download references

Acknowledgements

We are very grateful to H Bose (University of Texas, Austin, TX, USA) for the IκBα cDNA clone, N Rice (ABL-NCI, Frederick, MD, USA) for anti-p40/IκBα antibody #1275, T Gilmore (Boston University, Boston, MA, USA) for the c-rel cDNA, and K Nakayama (Kanazawa University, Japan) for pIL6κBCAT. We thank J Bash, LC Edelstein and M Hannink for fruitful discussions during the course of this work and B Rayet for assistance with the correction of the proofs. This work was supported by National Institutes of Health grant CA-54999 from the National Cancer Institute (C Gélinas) and by the New Jersey Commission on Science and Technology. I Luque was supported by a post-doctoral fellowship from the International Human Frontier Science Program. C Chen was supported by a post-doctoral fellowship from the New Jersey Commission on Cancer Research and by the Foundation of UMDNJ.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luque, I., Zong, Wx., Chen, C. et al. N-terminal determinants of IκBα necessary for the cytoplasmic regulation of c-Rel. Oncogene 19, 1239–1244 (2000). https://doi.org/10.1038/sj.onc.1203400

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203400

Keywords

This article is cited by

Search

Quick links